| Venlafaxine is new generic Effexor XR [message #23] |
Wed, 30 June 2010 08:35 |
 |
Pharmacist Messages: 4 Registered: November 2009 |
Junior Member Administrator |
|
|
Teva Pharmaceutical Industries Ltd. said Tuesday that the Food and Drug Administration approved its generic version of Pfizer Inc.' antidepressant Effexor XR.
Teva said it will start shipping its version of Effexor, or venlafaxine, on Thursday. The Israeli company originally sought approval for its generic in 2006, but as part of a patent settlement with Wyeth, it agreed not to sell its version until July 1, 2010. Pfizer acquired Wyeth last year.
Teva said annual U.S. sales of Effexor XR are around $2.75 billion. The world's largest generic drugmaker will have 180 days of marketing exclusivity for its drug, meaning the FDA will not clear any other versions for about six months.
|
|
|